WorldCat Linked Data Explorer

Turtle N-Triple JSON-LD RDF/XML HTML Contact Us Home

http://worldcat.org/entity/work/id/796131416

Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry

The pharmaceutical industry is in a dire situation: R&D still produces no more drugs than 10 years ago, while costs have quadrupled in the meantime. Little advances have been made in innovation efficiency. Worse yet, drug development times are unacceptably long, possible drug development targets are waning, and national healthcare is tightening the cost squeeze. A predictable and efficient pipeline of drug candidates, coupled with a handful of blockbuster drugs, is considered the Holy Grail of pharmaceutical innovation. In this book, the authors develop a case for mastering pharmaceutical innovation focusing on three leading sources of future pharmaceutical competitiveness: new technologies and techniques, better pipeline management, and stronger integration of external innovation. Illustrated with plenty of real-life cases, this book tells you how to put the principles of leading pharmaceutical innovation into practice.

Open All Close All

type

about

http://schema.org/about

author

contributor

creator

description

http://schema.org/description

  • "The pharmaceutical industry is in a dire situation: R&D still produces no more drugs than 10 years ago, while costs have quadrupled in the meantime. Little advances have been made in innovation efficiency. Worse yet, drug development times are unacceptably long, possible drug development targets are waning, and national healthcare is tightening the cost squeeze. A predictable and efficient pipeline of drug candidates, coupled with a handful of blockbuster drugs, is considered the Holy Grail of pharmaceutical innovation. In this book, the authors develop a case for mastering pharmaceutical innovation focusing on three leading sources of future pharmaceutical competitiveness: new technologies and techniques, better pipeline management, and stronger integration of external innovation. Illustrated with plenty of real-life cases, this book tells you how to put the principles of leading pharmaceutical innovation into practice."@en
  • "Pharmaceutical innovation is like gambling at roulette, only the stakes are higher. Considerably higher, since the most recent estimates put the costs of drug development at US$ 800 million to US$ 1 billion - per drug! This is equivalent to the price tag of the Empire State Building, when it was for sale a few years ago. In 2001, the major US and European pharmaceutical companies invested more than US$ 30 billion in R&D, at a higher R&D to-sales ratio than virtually any other industry, including chemicals, auto mobiles, electronics, aerospace, and computers. Delivering a blockbuster drug is the Holy Grail for any pharmaceutical company. But in the last decade the rules of developing blockbusters seem to have changed. On the one hand, more sophisticated screening technolo gies, genetic engineering, and expanding networks with biotechnology companies increase the probability of commercial success. Critical success factors include the discovery phase and a stronger outside-in orientation in the early innovation phase. After the implosion of the high-tech stock mar ket, biotechnology and other technology-driven opportunities may have lost some of their attractiveness for big pharma: a pipeline of solid and predictable innovations seems to be the highest goal of most pharmaceuti cal companies again. On the other hand, despite significant investments in pipeline management and novel technologies, there is still no recipe for ensuring a blockbuster hit."
  • "Pharmaceutical giants have doubled their investments in drug development in the past only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices."@en

genre

http://schema.org/genre

  • "Case studies"@en
  • "Case studies"
  • "Electronic books"
  • "Ressources Internet"
  • "Electronic books"@en
  • "Elektronisches Buch"

name

http://schema.org/name

  • "Leading Pharmaceutical Innovation : Trends and Drivers for Growth in the Pharmaceutical Industry"
  • "Leading pharmaceutical innovation : Trends and drives for growth in the pharmaceutical industry"
  • "Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry"@en
  • "Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry"
  • "Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical Industry"
  • "Leading Pharmaceutical Innovation Trends and Drivers for Growth in the Pharmaceutical Industry"
  • "Leading Pharmaceutical Innovation Trends and Drivers for Growth in the Pharmaceutical Industry"@en
  • "Leading pharmaceutical innovation trends and drivers for growth in the pharmaceutical industry"@en
  • "Leading pharmaceutical innovation trends and drivers for growth in the pharmaceutical industry"

workExample